Pharmafile Logo

payer survey

- PMLiVE

UK hits ‘significant milestone’ as 15 million people receive their first COVID-19 vaccine dose

The NHS also announced that five additional large-scale vaccination centres will open this week

- PMLiVE

New survival data for Merck, Eisai’s Keytruda/Lenvima combination shows promise in kidney cancer

Data presented at the virtual American Society of Clinical Oncology’s Genitourinary Cancers Symposium

- PMLiVE

Pfizer’s basic instincts

Business model evolution can’t defy strategic gravity

- PMLiVE

AZ/Oxford University’s COVID-19 vaccine to be evaluated in children and young adults

First study to assess the safety and immune response of the vaccine in children

- PMLiVE

STEM Healthcare founder Rob Wood secures a 25% stake in performance-io

performance-io launched three years ago as pharma’s first ‘performance marketing’ agency

- PMLiVE

Roche’s anti-inflammatory drug reduces deaths in hospitalised COVID-19 patients

Tocilizumab, marketed as Actemra/RoActemra, also reduced time spent in hospital in RECOVERY trial

- PMLiVE

EMA begins rolling review of CureVac’s COVID-19 vaccine

Investigational vaccine is currently being evaluated in a phase 2/3b clinical trial

- PMLiVE

Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m

Sandoz, the generics division of Novartis, will pay $350m upfront for three established brands

Virgo Health appoints Sarah Gordon as head of health

Gordon has worked at the health communications and medical education agency since 2018

- PMLiVE

We Celebrate Your Whole Selves: That’s What Makes The Magic

People are at the heart of who we are. Our aim is to transform the lives of those we touch without prejudice or discrimination. At Lucid, the magic we create...

Lucid Group Communications Limited

- PMLiVE

Q&A: Emily Spilko

PME interviews Evoke's Executive Creative Director

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links